Home › Funds › Integral Health Asset Management, LLC › SYRE

Integral Health Asset Management, LLC position in SYRE

SPYRE THERAPEUTICS INC · Health Care

Integral Health Asset Management, LLC reported holding 325,000 shares of SYRE (SPYRE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$28.9M, representing 1.30% of its reported portfolio and ranking #25 among its reported holdings. Integral Health Asset Management, LLC has disclosed SYRE holdings in 3 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)325.00K sh
Reported value held$28.85M
Portfolio Weight1.30%
First reportedQ1 2024
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's SYRE position evolved

Integral Health Asset Management, LLC first disclosed a stake in SYRE in Q1 2024 at 100,000 shares (US$3.8M). The position peaked in Q2 2026 at 325,000 shares, worth US$28.9M. Across 3 filings, Integral Health Asset Management, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 325,000 shares valued at US$28.9M.

Quarter by quarter

QuarterSharesValueChange
Q1 2024 100.00K $3.79M New
Q2 2024 100.00K $2.35M Hold
Q2 2026 325.00K $28.85M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SYRE and 13F data

SYRE (SPYRE THERAPEUTICS INC) is a Health Care company. 70 other funds we track also report a position in SYRE — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$383.5M), RTW INVESTMENTS, LP (US$377.5M), Paradigm Biocapital Advisors LP (US$341.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SYRE

All SYRE fund holders →

FAQ

How long has Integral Health Asset Management, LLC held SYRE?

Integral Health Asset Management, LLC has disclosed SYRE holdings in 3 of the last 10 reported quarters, going back to Q1 2024.

What is Integral Health Asset Management, LLC's current position in SYRE?

As of Q2 2026, Integral Health Asset Management, LLC holds 325.00K shares of SYRE (SPYRE THERAPEUTICS INC), valued at $28.85M, representing 1.30% of its reported portfolio and ranking #25.

Has Integral Health Asset Management, LLC been buying or selling SYRE?

In the latest 13F filing (Q2 2026), Integral Health Asset Management, LLC newly opened its position in SYRE. The position peaked in Q2 2026 at 325.00K shares.

Which other funds hold SYRE?

Other major institutional holders of SYRE include PERCEPTIVE ADVISORS LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.